Wednesday 25 April 2012

Inventor of Abiraterone Recommends Salvestrols

Abiraterone was discovered by Professor Gerry Potter in 1990 at the Institute of Cancer Research at the Royal Marsden Hospital in the UK. This is formulated as Abiraterone Acetate (Zytiga) for the treatment of metastatic prostate cancer. Ten years later Professor Potter discovered salvestrols which work against all types of cancer and are effective against prostate cancer. This has been formulated as the product Salvestrol Platinum which is recommended for all types of cancer.

For first line therapy salvestrols are useful since they do not suffer from any bad side effects, and are completely safe to take on a daily basis.

For patients relapsed on Zytiga or other hormonal therapies, salvestrols can be taken with good effect since they work by a hormone independent pathway.

No comments:

Post a Comment